“Puzzlingâ€: Farapulse trial investigator on the device’s use beyond recommendations
One-year data from Boston Scientific’s FARADISE registry demonstrated the strong efficacy of its Farapulse PFA system yet also revealed that some users are ablating more targets than necessary.